C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/09 (2006.01) C07K 14/315 (2006.01) C12N 15/31 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2123579
The invention relates to DNA sequences encoding epitopes which are used in recombinant multivalent hybrid protein vaccines to control group A streptococcal infections of multiple serotypes which may result in rheumatic fever.
Dale James B.
Lederer James W. Jr.
Smart & Biggar
The University Of Tennessee Research Corporation
University Of Tennessee Research Foundation
LandOfFree
Recombinant multivalent m protein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant multivalent m protein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant multivalent m protein vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1633321